Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1376

1

Olema Pharmaceuticals, Inc. Olema Pharmaceuticals Reports $129.4 Million Net Loss for 2024, Increased R&D Expenses

Via official filing (AI summary) | about 1 month ago | 0 comments

1377

1

Natera, Inc. Natera Reports 56.7% Revenue Growth to $1.7 Billion in 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1378

1

MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports $259.6M Net Loss and 10.3% Revenue Decline for 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1379

1

MASTEC INC MasTec Inc. Reports $199.4 Million Net Income and $12.3 Billion Revenue for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1380

1

Grayscale Bitcoin Trust ETF Grayscale Bitcoin Trust ETF Reports $16.38 Million Gain for 2024, Sees 27% Decrease in Net Assets

Via official filing (AI summary) | about 1 month ago | 0 comments

1381

1

VERACYTE, INC. Veracyte Reports $24.1 Million Net Income and 23% Revenue Growth for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1382

1

Trevi Therapeutics, Inc. Trevi Therapeutics Reports $47.9 Million Net Loss for 2024, Increases R&D Spending

Via official filing (AI summary) | about 1 month ago | 0 comments

1383

1

Cytek Biosciences, Inc. Cytek Biosciences Reports $200.5M Revenue and $6M Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1384

1

LENZ Therapeutics, Inc. LENZ Therapeutics Reports $49.77 Million Net Loss for 2024, Prepares for LNZ100 Launch

Via official filing (AI summary) | about 1 month ago | 0 comments

1385

1

NB Bancorp, Inc. NB Bancorp Reports $42.1 Million Net Income for 2024, Driven by Loan Growth

Via official filing (AI summary) | about 1 month ago | 0 comments

1386

1

SURO CAPITAL CORP. SuRo Capital Reports $13.95 Million Net Investment Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1387

1

MANGOCEUTICALS, INC. Mangoceuticals Reports $615,873 Revenue and $8.7M Net Loss for 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1388

1

ALUMIS INC. Alumis Inc. Reports $294.2 Million Net Loss for 2024, Announces Merger with ACELYRIN Inc.

Via official filing (AI summary) | about 1 month ago | 0 comments

1389

1

SERA PROGNOSTICS, INC. Sera Prognostics Reports $32.9 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1390

1

Biofrontera Inc. Biofrontera Inc. Reports $17.8 Million Net Loss and $37.3 Million Revenue for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1391

1

MetaVia Inc. NeuroBo Pharmaceuticals Reports $27.6 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1392

1

ACELYRIN, Inc. Acelyrin Reports $248.2 Million Net Loss for 2024, Announces Merger with Alumis Inc.

Via official filing (AI summary) | about 1 month ago | 0 comments

1393

1

Century Therapeutics, Inc. Century Therapeutics Reports $126.6 Million Net Loss for 2024, Collaboration Revenue Increases

Via official filing (AI summary) | about 1 month ago | 0 comments

1394

1

Senti Biosciences, Inc. Senti Biosciences Reports $52.8 Million Net Loss for 2024, Initiates Phase 1 Clinical Trials

Via official filing (AI summary) | about 1 month ago | 0 comments

1395

1

Galecto, Inc. Galecto, Inc. Reports $21.4 Million Net Loss for 2024, Highlights Strategic Acquisition and Operational Changes

Via official filing (AI summary) | about 1 month ago | 0 comments

1396

1

Amprius Technologies, Inc. Amprius Technologies Reports 167% Revenue Growth to $24.2 Million, Faces Increased Losses

Via official filing (AI summary) | about 1 month ago | 0 comments

1397

1

Eledon Pharmaceuticals, Inc. Eledon Pharmaceuticals Reports Improved Financial Performance and Focus on Kidney Transplantation Programs

Via official filing (AI summary) | about 1 month ago | 0 comments

1398

1

AVALON HOLDINGS CORP Avalon Holdings Reports 5% Revenue Decline and Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments

1399

1

Kalaris Therapeutics, Inc. AlloVir Reports $58.77 Million Net Loss for 2024, Announces Merger with Kalaris Therapeutics

Via official filing (AI summary) | about 1 month ago | 0 comments

1400

1

AMERICAN EAGLE OUTFITTERS INC American Eagle Outfitters Reports $5.329 Billion Revenue and 94% Net Income Increase for Fiscal Year 2024

Via official filing (AI summary) | about 1 month ago | 0 comments